{{htmlmetatags>
metatag-keywords=(Syndromes Geriatriques, Neurocognitif, SCPD, Agitation, Mirtazapine)
metatag-og:title=(Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Banerjee S, et al, Lancet 2021.): a randomised, double-blind, placebo-controlled trial. Banerjee S, et al, Lancet 2021.)
metatag-description=(Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Banerjee S, et al, Lancet 2021.): a randomised, double-blind, placebo-controlled trial. Banerjee S, et al, Lancet (London, England) 2021.)
metatag-og:type=article
metatag-article:published_time=2021-11-20
metatag-article:modified_time=2021-11-20
}}
{{page>:priv:keywords&nofooter&noeditbtn}}
~~NOTOC~~
{{pmid>addtt:34688369|Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.}}
{{pmid>addhash_fr:34688369|Syndromes_Geriatriques, SCPD, Agitation, Mirtazapine}}
====== Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Banerjee S, et al, Lancet 2021. ======
{{tag>Syndromes_Geriatriques Neurocognitif }}
{{tag>SCPD, Agitation, Mirtazapine}}
* **Proposé le :** 20/11/2021 13:08:49
* **Par :** [[:user:tweetuser]]
* **Avec la version du site :**
* **Revu par :**
* //Mettre votre nom d'utilisateur//
* //Mettre votre nom d'utilisateur//
{{tag>Proposé_à_relecture 2021-11 Non_attribué Non_finalisé}}
{{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}}
===== Résumé et points clés =====
{{pmid>abstract_html:34688369}}
===== Références de l'article =====
{{pmid>listgroup:34688369}}
----
{{page>:veille:pm:discussion:34688369&nofooter&nolink&noindent}}
[[:veille:pm:discussion:34688369?do=edit|Éditer la discussion]]
----
===== Références =====
~~REFNOTES~~